Lahav Gil and Nir Katchinskiy, PhD - Pulse Medica

A Laser-Focused Business Model, With Nir Katchinskiy and Lahav Gil

By Priscilla Villarreal | February 2, 2022

  PODCAST EPISODE 315 Click here to watch the video version of this podcast. Retina specialists have limited imaging and surgical tools to visualize the…

Read More
Daniel Chao, MD, PhD, Janssen - Johnson & Johnson

The Coast to Coast Journey from Academic Research to Janssen Pharmaceuticals with Daniel Chao, MD, PhD

By Priscilla Villarreal | January 25, 2022

PODCAST EPISODE 314 Click here to watch the video version of this podcast. Daniel Chao, MD, PhD, spent a lot of years in the lab…

Read More
Sharon Bakalash, MD, PhD, CBA - Panel

Here’s What’s New in Drug Delivery

By Priscilla Villarreal | January 19, 2022

PODCAST EPISODE 313 Click here to watch the video version of this podcast. A new generation of drug-delivery technology is emerging, with new refillable, absorbable, and…

Read More
Brian Strem - Kiora Pharmaceuticals

Passionate Pursuits With Kiora Pharmaceuticals Brian Strem

By Priscilla Villarreal | January 12, 2022

PODCAST EPISODE 312 Click here to watch the video version of this podcast. Brian Strem, president and CEO of Kiora Pharmaceuticals, didn’t plan to become…

Read More
Lori-Ann Christie - Visionary

Lori-Ann Christie’s Detour to Venture Capital With Visionary Ventures

By Priscilla Villarreal | January 5, 2022

PODCAST EPISODE 311 Click here to watch the video version of this podcast. A college detour from medical school and into scientific research worked to…

Read More

Calculating Both Sides of the Doctor-Patient Equation, with Diana Driscoll, OD

By Priscilla Villarreal | December 8, 2021

PODCAST EPISODE 309 Click here to watch the video version of this podcast. Even the most experienced physicians encounter patients with conditions they can’t solve…

Read More

Faster, Better, Smarter, Cheaper With MacuLogix’s Bill McPhee

By Rich Kirkner | November 17, 2021

Even the most groundbreaking device won’t go far if doctors can’t easily adopt it into their practice. PODCAST EPISODE 306

Read More

Six Oral Retina Drug Development Programs to Watch

By Heather Johnson | November 10, 2021

Intravitreal anti-vascular endothelial growth factor (VEGF) therapy slows or stops damage that occurs in wet age-related macular degeneration (AMD), diabetic retinopathy (DR), and other retinal…

Read More

Opus Genetics: RD Fund’s First Spinout to Advance Gene Therapies for Inherited Retinal Diseases

By Priscilla Villarreal | November 3, 2021

The Retinal Degeneration Fund (RD Fund), the venture philanthropy arm of The Foundation Fighting Blindness (FFB), recently launched the first company to come out of…

Read More

DIY Commercialization, with Olympic Ophthalmics’ Michael Gertner, MD

By Priscilla Villarreal | November 3, 2021

Many medical device start-ups seek acquisition to secure the financial and operational resources they need to obtain regulatory approval and gain market access. Michael Gertner,…

Read More

OIS Glaucoma Showcase Take-Home: Glaucoma Market Poised For Growth

By Karen Blum | October 26, 2021

A growing number of people living past age 60 years, innovation to increase the effectiveness or accessibility of care, and competition are the largest factors…

Read More

Nine Days in September: Three Pharma Plays in Gene Therapy

By Karen Blum | October 20, 2021

All eyes turned to gene therapy for nine days in September, as three large pharmaceutical companies—AbbVie, Théa, and Novartis—initiated moves to foster the development of…

Read More


Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.